key: cord-0959598-midlue01
authors: Schönborn, Linda; Thiele, Thomas; Kaderali, Lars; Greinacher, Andreas
title: Decline in Pathogenic Antibodies over Time in VITT
date: 2021-09-08
journal: N Engl J Med
DOI: 10.1056/nejmc2112760
sha: 32195b383d3dc0d45685f68ba846c5789ec6603a
doc_id: 959598
cord_uid: midlue01

nan

We identified all patients referred to our laboratory with the clinical suspicion of VITT in whom we had confirmed the diagnosis by a positive anti-PF4/heparin IgG enzyme linked immunosorbent assay (ELISA) and by demonstrating antibodies inducing PF4dependent platelet activation. We contacted the physicians who referred the patients at the time of acute VITT; they forwarded informed consent documents to the patients and/or their legal guardian. The patient provided contact data and consent. Later the attending physician (family physicians, hematologists, or physicians of hospitals or rehabilitation institutions) periodically referred serum samples (obtained during routine follow-up visits) for anti-PF4 antibody testing.

Time of vaccination and onset of symptoms were retrieved from the laboratory documentation obtained during initial diagnosis. In case of missing data, patients were contacted via telephone or e-mail to complete the dataset. In addition, when a second dose of SARS-CoV-2 vaccine was given, we obtained information about the clinical course after vaccination and obtained a serum sample one to six weeks after vaccination.

Anti-PF4 IgG antibodies were tested by PF4/heparin ELISA. 1 The cut-off of the ELISA was defined as optical density (OD) 0.5; samples testing >0. 

Statistical analysis was performed in R, version 4.1.0. 3 As follow-up times are censored and differ between study participants, PF4/heparin ELISA assays and functional tests were analyzed using the Kaplan-Meier method. A threshold of 2 was used to dichotomize the anti-PF4/heparin IgG antigen assay after linear interpolation between measurement time points. Patients that achieved negative and then relapsed to positive functional test results were considered positive at all times. Confidence intervals for Kaplan-Meier estimates were computed using Greenwood's method, confidence intervals for the binomial distribution were computed using Wilson's approximation. A one-sided, paired Wilcoxon's signed rank test was used to compare optical densities of the first and last PF4 / heparin Elisa measurement per patient.

The study was approved by the ethics board of the University Medicine Greifswald (BB 052/21a) and registered at the German Clinical Trials Register (DRKS00025738).

Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

R: A language and environment for statistical computing. R foundation for statistical Computing

We are grateful to all the patients and treating physicians who send blood samples for follow-up and provided us with clinical information. We especially thank Dr Günther, Universitätsmedizin Jena and Dr Leng, Charité Berlin for very helpful discussions and support.

The study has been funded by the Deutsche Forschungsgemeinschaft (DFG, GermanResearch Foundation) grants: 374031971 -TRR240Dr. Schönborn was supported within the Gerhard-Domagk-Research-Program by the University Medicine Greifswald.